The Triglyceride-Glucose Index is Associated with Vitamin D Status in Metabolic-Associated Fatty Liver Disease

References

• Lazarus JV, Mark HE, Anstee QM, et al. NAFLD Consensus Consortium. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19(1):60–78. doi:10.1038/s41575-021-00523-4
   PubMed Web of Science ®Google Scholar
• Rinaldi L, Pafundi PC, Galiero R, et al. Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. a narrative review. Antioxidants. 2021;10(2):270. doi:10.3390/antiox10020270
   Web of Science ®Google Scholar
• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Jiang Z, Pu R, Li N, et al. High prevalence of vitamin D deficiency in Asia: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2021;16:1–10. doi:10.1080/10408398.2021.1990850
   Google Scholar
• Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012;57(4):897–909. doi:10.1016/j.jhep.2012.04.033
   PubMed Web of Science ®Google Scholar
• Guo XF, Wang C, Yang T, et al. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Food Funct. 2020;11(9):7389–7399. doi:10.1039/d0fo01095b
   PubMed Web of Science ®Google Scholar
• Guan Y, Xu Y, Su H, et al. Effect of serum vitamin D on metabolic associated fatty liver disease: a large population-based study. Scand J Gastroenterol. 2022;57(7):862–871. doi:10.1080/00365521.2022.2039284
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi:10.1089/met.2008.0034
   PubMedGoogle Scholar
• Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351. doi:10.1210/jc.2010-0288
   PubMed Web of Science ®Google Scholar
• Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride Glucose (TyG) Index: a surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022;72(5):986–988. doi:10.47391/JPMA.22-63
   PubMed Web of Science ®Google Scholar
• Lee SB, Kim MK, Kang S, et al. Triglyceride Glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean adults. Endocrinol Metab. 2019;34(2):179–186. doi:10.3803/EnM.2019.34.2.179
   Web of Science ®Google Scholar
• Wang J, Yan S, Cui Y, et al. The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): a Systematic Review and Meta-Analysis. Nutrients. 2022;14(23):4969. doi:10.3390/nu14234969
   PubMed Web of Science ®Google Scholar
• Liu Z, He H, Dai Y, et al. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study. Lipids Health Dis. 2022;21(1):55. doi:10.1186/s12944-022-01661-7
   PubMed Web of Science ®Google Scholar
• Jia Y, Song T, Li Z, Zhou L, Chen S. The Relationship Between Triglyceride Glucose Index and Vitamin D in Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2022;15:511–525. doi:10.2147/DMSO.S348845
   PubMed Web of Science ®Google Scholar
• Xiang Q, Xu H, Zhan J, et al. Association between the Triglyceride-Glucose Index and Vitamin D Status in Type 2 Diabetes Mellitus. Nutrients. 2023;15(3):639. doi:10.3390/nu15030639
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503–508. doi:10.1016/j.dld.2009.08.002
   PubMedGoogle Scholar
• Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9(12):941–955. doi:10.1038/nrd3318
   PubMed Web of Science ®Google Scholar
• Kim HS, Rotundo L, Kothari N, Kim SH, Pyrsopoulos N. Vitamin D Is Associated with Severity and Mortality of Non-alcoholic Fatty Liver Disease: a US Population-based Study. J Clin Transl Hepatol. 2017;5(3):185–192. doi:10.14218/JCTH.2017.00025
   PubMedGoogle Scholar
• Ha Y, Hwang SG, Rim KS. The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: a Population-Based Study. Nutrients. 2017;9(8):806. doi:10.3390/nu9080806
   PubMed Web of Science ®Google Scholar
• Dutra JDM, Lisboa QC, Ferolla SM, et al. Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population. Int J Vitam Nutr Res. 2021;91(5–6):411–418. doi:10.1024/0300-9831/a000667
   PubMed Web of Science ®Google Scholar
• Wan B, Gao Y, Zheng Y, et al. Association between serum 25-hydroxy vitamin D level and metabolic associated fatty liver disease (MAFLD)-a population-based study. Endocr J. 2021;68(6):631–637. doi:10.1507/endocrj.EJ20-0758
   PubMed Web of Science ®Google Scholar
• Szymczak-Pajor I, Drzewoski J, Śliwińska A. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci. 2020;21(18):6644. doi:10.3390/ijms21186644
   PubMed Web of Science ®Google Scholar
• Sangouni AA, Ghavamzadeh S, Jamalzehi A. A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr. 2019;13(3):2260–2265. doi:10.1016/j.dsx.2019.05.013
   PubMed Web of Science ®Google Scholar
• Sharifi N, Amani R. Vitamin D supplementation and non-alcoholic fatty liver disease: a critical and systematic review of clinical trials. Crit Rev Food Sci Nutr. 2019;59(4):693–703. doi:10.1080/10408398.2017.1389693
   PubMed Web of Science ®Google Scholar
• Mirshafiei H, Darroudi S, Ghayour-Mobarhan M, et al. Altered triglyceride glucose index and fasted serum triglyceride high-density lipoprotein cholesterol ratio predict incidence of cardiovascular disease in the Mashhad cohort study. Biofactors. 2022;48(3):643–650. doi:10.1002/biof.1816
   PubMed Web of Science ®Google Scholar
• Kim YM, Kim JH, Park JS, et al. Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric Cancer. 2022;25(1):33–41. doi:10.1007/s10120-021-01222-4
   PubMed Web of Science ®Google Scholar
• O’Hagan R, Gonzalez-Cantero A, Patel N, et al. Association of the triglyceride glucose index with insulin resistance and subclinical atherosclerosis in psoriasis: an observational cohort study. J Am Acad Dermatol. 2023;88(5):1131–1134. doi:10.1016/j.jaad.2022.08.027
   PubMed Web of Science ®Google Scholar
• Chen XX, Rastogi D. Triglyceride-Glucose Index: a Potential New Biomarker for Lung Disease Associated with Metabolic Dysregulation. Chest. 2021;160(3):801–802. doi:10.1016/j.chest.2021.04.027
   PubMed Web of Science ®Google Scholar
• Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13:951689. doi:10.3389/fendo.2022.951689
   PubMed Web of Science ®Google Scholar
• Taheri E, Pourhoseingholi MA, Moslem A, et al. The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults. J Diabetes Metab Disord. 2022;21(1):97–107. doi:10.1007/s40200-021-00941-w
   PubMed Web of Science ®Google Scholar
• Dhas Y, Banerjee J, Damle G, Mishra N. Association of vitamin D deficiency with insulin resistance in middle-aged type 2 diabetics. Clin Chim Acta. 2019;492:95–101. doi:10.1016/j.cca.2019.02.014
   PubMed Web of Science ®Google Scholar
• Mustafa A, Shekhar C. Association between serum 25-hydroxyvitamin-D and Triglycerides-Glucose index among Indian adolescents. BMC Nutr. 2022;8(1):69. doi:10.1186/s40795-022-00568-x
   PubMedGoogle Scholar
• Mohamad MI, El-Sherbeny EE, Bekhet MM. The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus. J Am Coll Nutr. 2016;35(5):399–404. doi:10.1080/07315724.2015.1026427
   PubMed Web of Science ®Google Scholar
• Surdu AM, Pînzariu O, Ciobanu DM, et al. Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis. Biomedicines. 2021;9(2):172. doi:10.3390/biomedicines9020172
   PubMed Web of Science ®Google Scholar
• Asano L, Watanabe M, Ryoden Y, et al. Vitamin D Metabolite, 25-Hydroxyvitamin D, Regulates Lipid Metabolism by Inducing Degradation of SREBP/SCAP. Cell Chem Biol. 2017;24(2):207–217. doi:10.1016/j.chembiol.2016.12.017
   PubMed Web of Science ®Google Scholar
• Lee SM, Jun DW, Cho YK, Jang KS. Vitamin D deficiency in non-alcoholic fatty liver disease: the chicken or the egg? Clin Nutr. 2017;36(1):191–197. doi:10.1016/j.clnu.2015.10.017
   PubMed Web of Science ®Google Scholar